Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

BMRN $128.78 13.2300 +11.45%
CALA $17.45 1.5700 +9.89%
VICL $0.92 0.0677 +7.92%
MRTX $28.42 2.0500 +7.77%
NLNK $52.26 3.3300 +6.81%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

OHRP $2.74 -5.9900 -68.61%
LOXO $12.37 -1.0450 -7.79%
IMDZ $24.09 -1.5600 -6.08%
CNDO $3.58 -0.2200 -5.79%
MEIP $1.74 -0.0900 -4.92%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next > | Last >>

mHealth App Ideal For Breast Cancer Risk Assessment, Prevention

(Dartmouth-Hitchcock/Norris Cotton CC) Mar 18, 2015 - Interviewing women at a breast-imaging center in an urban safety net institution before and after they used a "mHealth" mobile health app on a tablet, Elissa Ozanne, PhD from Dartmouth's Norris Cotton Cancer Center and colleagues concluded that older, diverse, and low income women found it easy to use and acceptable.
read press release 

Predicted Deaths of Young Women With Breast Cancer Underestimated By a Quarter

(Cancer Research UK) Mar 18, 2015 - An online computer programme that helps to predict the most suitable treatment for breast cancer has been found to underestimate the number of women under 40 who will die from the disease by 25 per cent, according to a study published in the British Journal of Cancer today.
read press release 

Macrophages May Play Critical Role in Melanoma Resistance to BRAF Inhibitors

(The Wistar Institute) Mar 17, 2015 - In the last several years, targeted therapies – drugs that directly impact specific genes and proteins involved in the progression of cancer – have been approved for a wide variety of cancers, including melanoma, the deadliest form of skin cancer.
read press release 

World-First Cancer Drugs Could Work in Larger Group of Patients

(ICR [UK]) Mar 19, 2015 - A pioneering class of drugs that target cancers with mutations in the BRCA breast cancer genes could also work against tumours with another type of genetic fault, a new study suggests.
read press release 

Tykerb Still Falls Short in HER2-Positive Breast Ca

(MedPage Today/The Gupta Guide) Mar 18, 2015 - In HER2-positive breast cancer, lapatinib (Tykerb) combined with a taxane was linked to shorter progression-free survival (PFS) and more toxicity compared with trastuzumab (Herceptin) plus a taxane, according to results from an international trial.
read article (free registration required) 

New Data Investigating Merck’s KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer and Mesothelioma to Be Presented in Clinical Trials Plenary Session at AACR 2015

(MarketWatch) Mar 18, 2015 - Merck today announced that new data evaluating KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, in both advanced non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma will be presented as part of the Clinical Trials Plenary Session on Sunday, April 19 at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia, April 18 – 22.
read article 

Lawmakers Unveil Bill to Prevent Medicare Cuts to Doctors

(The Hill) Mar 19, 2015 - Bipartisan committee leaders in the House and Senate introduced legislation Thursday to permanently end automatic cuts to doctors under Medicare.
read article 

Community Oncology Alliance Announces Support of Bill to Help Stabilize the Nation's Deteriorating Cancer Care Delivery System

(Yahoo! Finance) Mar 19, 2015 - The bipartisan bill stops the Centers for Medicare & Medicaid Services (CMS) from inappropriately applying the Medicare sequester cut to the underlying payment for cancer drugs and other Part B therapies.
read article 

New Global Fund to Help Countries Defend Smoking Laws

(New York Times) Mar 18, 2015 - Bloomberg Philanthropies and the Bill & Melinda Gates Foundation announced on Wednesday that they had started a global fund to help low- and middle-income countries fight legal challenges to their smoking laws by the tobacco industry.
read article 

AstraZeneca Says New Lung Drug Combination Improves Breathing

(Bloomberg) Mar 18, 2015 - AstraZeneca Plc said an experimental combination of lung drugs improved breathing function, potentially giving the U.K.’s second-largest drugmaker its second chronic obstructive pulmonary disease treatment.
read article 

Premera Blue Cross Says Cyberattack Could Affect 11 Million Members

(Wall Street Journal) Mar 17, 2015 - Health insurer Premera Blue Cross said hackers gained access to the personal information of around 11 million consumers, including bank account and clinical data for some.
read article (paid subscription required) 

FDA Panel to Discuss Ebola Vaccine Development in May

(Reuters) Mar 18, 2015 - The U.S. Food and Drug Administration said an advisory panel will discuss the development of Ebola vaccines, days after an American health worker was flown back after being tested positive for Ebola in Sierra Leone.
read article 

GSK, Theravance’s Breo Faces Scrutiny Over Safety for Asthma

(Bloomberg) Mar 17, 2015 - GlaxoSmithKline Plc and Theravance Inc.’s respiratory drug Breo Ellipta will face questions from a regulatory panel over the safety of expanding its use to treat asthma patients and whether it’s suitable for children.
read article 

Journey Forward and ERS Advance Survivorship Care Planning Through Data Integration

(MarketWatch) Mar 17, 2015 - Journey Forward, a leader in survivorship care planning, and Electronic Registry Services (ERS), a leading provider of cancer registry software, today announced a successful implementation that enhances the use of patient data in after-care plans.
read article 

XBiotech Launches Cancer Patient Directed Web Site and Call Center

(CenterWatch) Mar 16, 2015 - XBiotech has launched a web site and call center to help patients with metastatic colorectal cancer learn about its U.S. pivotal phase III clinical trial.
read article 

Cancer Screening Rates Improve, Disparities Shrink for Patients with Blue Cross Blue Shield of Michigan Patient-centered Medical Home Doctors

(Yahoo! Finance) Mar 17, 2015 - A new study published last month in JAMA Internal Medicine shows Blue Cross Blue Shield of Michigan's Patient-Centered Medical Home model improved overall cancer screening rates for colon, breast and cervical cancer.
read article 

Cell Medica Drug Gets Orphan Status

(PharmaTimes [UK]) Mar 18, 2015 - Immunotherapy firm Cell Medica has been granted orphan drug status in the USA for its drug to treat rare lymphomas.
read article 

Teva Teams with Ignyta on Oncology Treatment

(Globes [Israel]) Mar 18, 2015 - Teva is selling four targeted oncology development programs to Ignyta for 6% of the biotech company.
read article 

NantWorks And Sorrento Announce Second Comprehensive Global Collaboration On Discovery And Development Of Novel Anti-Cancer Immunotherapies

(Sorrento Therapeutics) Mar 16, 2015 - NantCell to acquire exclusive rights to antibodies including CAR-TNK™ products and the checkpoint inhibitors PD-1 and PD-L1.
read corporate press release 

NanoString Technologies' Prosigna Breast Cancer Assay Included in German Breast Cancer Treatment Guidelines

(Yahoo! News) Mar 18, 2015 - NanoString Technologies, Inc. today announced that its Prosigna® Breast Cancer Assay is now acknowledged within the treatment guidelines of the German Association of Gynecological Oncology (AGO).
read article 

Breast Implants to Carry Cancer Warning: Move Follows 18 Women in France Being Diagnosed with Rare Form of the Disease

(Daily Mail [UK]) Mar 18, 2015 - Breast implants in France will come with a health warning after experts discovered a link with a rare form of cancer.
read article 

NCCN Guide on CLL to Shift Toward Targeted Therapies

(Medscape Medical News) Mar 16, 2015 - Chemotherapy may soon take a backseat to ibrutinib as standard first-line therapy for chronic lymphocytic leukemia, investigators say. Changes in practice guidelines will likely follow.
read article (free registration required) 

NCCN: Forgo Lymph Node Biopsy in Thin Melanomas

(Medscape Medical News) Mar 16, 2015 - Not every melanoma needs a sentinel lymph node biopsy, and not every positive biopsy needs full dissection.
read article (free registration required) 

NCCN Guidance on New Castration-Resistant Prostate Therapies

(Medscape Medical News) Mar 17, 2015 - A better understanding of prostate cancer biology is paying off in new therapies that promise to extend survival in men with castration-resistant tumors. The guidelines reflect the new data.
read article (free registration required) 

Guide Stresses BCG for Bladder Maintenance After Induction

(Medscape Medical News) Mar 17, 2015 - The updated NCCN guidelines recommend maintenance with Bacillus Calmette-Guérin (BCG) for patients who receive induction immunotherapy with the compound, but BCG is in short supply.
read article (free registration required)